Posts Tagged: melanoma
Key Risk Factors Affecting Treatment Choice in Melanoma with Dr. G. Gary Tian
Key Risk Factors Affecting Treatment Choice in Melanoma West provider, Dr. G. Gary Tian, joins Dr. Evan J. Lipson with John Hopkins Medicine and other oncology experts to discuss critical factors influencing physicians’ decisions between monotherapy and doublet therapy for Metastatic Melanoma. The group dives into the latest treatment options for metastatic melanoma,… Read more »
100% Response Rate in Skin Cancer Trial
Our West family is 1 of only 2 sites across the country to host this clinical trial for patients with recurrent or unresectable skin cancers. “After 12 weeks post-treatment, complete response was observed in all 10 patients (100%)! CT scans at 24 weeks post-treatment showed NO EVIDENCE OF RECURRENT DISEASE in any of the patients.”… Read more »
Meet Amy: Metastatic Melanoma Survivor
MEET AMY: SURVIVOR OF METASTATIC MELANOMA OF THE LUNGS & BRAIN What a warrior! Amy’s cancer journey has been a wild ride – but her optimism, perseverance, and drive to advocate for her own health (and others) has been her motivation! Amy shares details of her personal battle with cancer in the video below, and… Read more »
Dr. Matthew Ballo on WREG for Skin Cancer Awareness
Radiation Oncologist, Dr. Matthew Ballo, was recently featured on WREG News Channel 3‘s “3 Good Minutes” to share information about sun safety and updates in skin cancer treatments and research! He shares “Taking care of your skin and avoiding skin cancer is kind of like taking care of your car. You need to do regular… Read more »
Reversing resistance to PD-1 inhibitors with combination immunotherapy in patients with advanced melanoma
West Cancer Center & Research Institute’s Ari Vanderwalde, MD, MPH is a SWOG (a National Cancer Institute supported organization that conducts clinical trials in adults) investigator and study chair for a trial that addresses advanced melanoma patients who are resistant to PD-1 inhibitors. Over 40% of these patients don’t respond to PD-1 inhibitors, widely used… Read more »
Metastatic Melanoma Survivor, Ken Billett, Shares His Journey
Meet Ken, a West Cancer Center metastatic melanoma survivor. Ken recently shared his Cancer Survivorship Story with us as we hope to spread these journeys of hope, achievement and encouragement this month! Here is Ken’s story: “My personal journey with #melanoma began long before my first #skincancer diagnosis. I grew up near… Read more »
ASCO 2021: Abstract Recommendations From Dr. Ari VanderWalde for Melanoma
Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »
2020 Top Stories in Advanced Melanoma: Drastic Improvement in Melanoma Mortality With Novel Agents
2020 Top Stories in Advanced Melanoma: Drastic Improvement in Melanoma Mortality With Novel Agents Written by Ari VanderWalde MD, MPH, FACP Despite a plethora of interesting findings and results of novel clinical trials in melanoma in 2020, I believe the most important story of the year was actually a small, easy-to-overlook, 3-page report in the American… Read more »